Forty Awardees Chosen for Their Outstanding Role in Advancing Patient Care
Maple Grove, MN – February 6, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are pleased to recognize the ... Read More
Pharmaceutical Company Highlights Past Achievements, Future Endeavors
Maple Grove, MN – January 28, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith), a US- based pharmaceutical company that has successfully delivered medications to the people who need them for ... Read More
Osaka, Japan – January 9, 2019 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) ... Read More
Osaka, Japan – December 13, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today announced the launch of six compounds with 14 strengths of generic drugs. They will be ... Read More
Osaka, Japan – December 5, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for RISEDRONATE SODIUM Tablets 17.5 mg [SAWAI]* and DOBUTAMINE HYDROCHLORIDE I.V. Infusion 100 mg [SAWAI]**.
This ... Read More
Osaka, Japan –November 21, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for LEVOFOLINATE I.V. Infusion 25 mg [SAWAI] and 100 mg [SAWAI]*.
This approval expands the indication of LEVOFOLINATE I.V. Infusion 25 mg [SAWAI] and 100 mg [SAWAI] to include the ... Read More
QUDEXY® XR’S ACCESS PATHWAYS® PROGRAM PLATINUM PASS™ FEATURED AT BOOTH #415
Maple Grove, MN – October 25, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the American Academy of Neurology (AAN) ... Read More
Clobazam Tablets, CIV, 10 and 20 mg Clobazam Oral Suspension, CIV, 2.5 mg/mL Upsher-Smith Laboratories, LLC
Maple Grove, MN – October 23, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clobazam Tablets, CIV, 10 ... Read More
NCPA AWARD SPONSORED BY UPSHER-SMITH FOR TENTH CONSECUTIVE YEAR
Maple Grove, MN – October 11, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) is pleased to announce that James “Jim” Spoon DPh, an independent pharmacist with deep roots ... Read More
